Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Six reasons to use PROPELTM sinus implants following sinus surgery

PROPEL™ implants are clinically proven to maintain patency and improve patient outcomes by reducing inflammation in the post-operative healing period.

Expand All

Individualized treatment options 1-3

  • ENT offers a family of 3 steroid-eluting implants under one brand: PROPEL™
  • PROPEL™ implants promote a tailored approach to postoperative care with options on implants’ indication, size, shape, and delivery system
  • The PROPEL™ implant provides localized delivery of mometasone furoate (MF), minimizing the reliance of patient compliance4
Learn more

Cutting-edge technology 1-3

Robust, clinically proven benefits 1-3

Proven success in CRS patients 1-5

Efficacious across multiple patient types4

ENT partnership and collaboration

Experts' perspective on PROPEL™ sinus implants

Watch Prof. Hesham Saleh, Prof. Jan Gosepath and Dr. David Conley discuss the benefits of using PROPEL™ following surgeries.

Watch the Q&A with Prof. Carl Philpott during CEORL 2024 

Watch the Q&A with Prof. Carl Philpott during CEORL 2024 congress in Dublin, Ireland.

PROPEL™ sinus implants facility tour

Get a sneak preview to the design and manufacturing of our unique and innovative family of sinus implants – PROPEL™.

PROPELTM family of sinus implants

The PROPEL™ family of implants offers 3 steroid-eluting implants under one brand, allowing ENT surgeons to select the best option that conforms to the anatomical needs of their patients1-3

Graphic images of the PROPEL, PROPEL Mini and PROPEL Contour.
Find out more on PROPEL™ family of sinus implants

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

References

1

PROPEL™ [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2013.

2

PROPEL™ Mini [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.

3

PROPEL™ Contour [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.

4

Han JK, Marple BF, Smith TL, et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol. 2012;2(4):271-279.

5

Data on file, Intersect ENT, Inc. Calculated Patients-PROPEL™ Family. Q2 2019.

6

Li PM, Downie D, Hwang PH. Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model. Am J Rhinol Allergy. 2009;23(6):591-596.

CRS, chronic rhinosinusitis; MF, mometasone furoate.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu

PROPEL™ Important Safety Information:
The PROPEL™ sinus implants are intended to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age following sinus surgery: PROPEL™ for the ethmoid sinus, PROPEL™ Mini for the ethmoid sinus/frontal sinus opening, and PROPEL™ Contour for the frontal sinus ostia in chronic rhinosinusitis patients. Contraindications include patients with intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. For full prescribing information see the device manuals. For use by healthcare professionals only.

Important Reminder: This information is intended only for users in markets where Medtronic products and therapies are approved or available for use as indicated within the respective product manuals. Content on specific Medtronic products and therapies is not intended for users in markets that do not have authorization for use.

PROPEL™ and PROPEL™ Mini:

CE Mark For Propel

PROPEL™ Contour:

CE Mark for Contour